Blueprint Medicines Lands $50,000,000 New Financing Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2ee0b85f-7140-4727-a41c-34c9bebf131e
Date 11/14/2014
Company Name Blueprint Medicines
Mailing Address 215 First Street Cambridge, MA 02142 USA
Company Description Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the growing understanding of the molecular blueprint of cancer.
Proceeds Purposes Proceeds from the financing will be used to advance Blueprint Medicines’ two lead product candidates through clinical trials in 2015 and fund the continued development of Blueprint Medicines’ kinase discovery platform and pipeline.